{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:33:02Z","timestamp":1771979582520,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["RO1AR040864"],"award-info":[{"award-number":["RO1AR040864"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013780","name":"Limb Girdle Muscular Dystrophy 2I Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AR074990"],"award-info":[{"award-number":["P30AR074990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AG079825"],"award-info":[{"award-number":["R44AG079825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtm.2023.05.022","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T13:44:48Z","timestamp":1685886288000},"page":"65-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficacy and muscle safety assessment of fukutin-related protein gene therapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Halli","family":"Benasutti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Maricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Halbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Wicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Huesgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Purvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Regnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buel D.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-0059","authenticated-orcid":false,"given":"Jeffrey S.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2023.05.022_bib1","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035931","article-title":"The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy","volume":"11","author":"Nickolls","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2023.05.022_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2023.05.022_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14473","article-title":"The functional o-mannose glycan on alpha-dystroglycan contains a phospho-ribitol primed for matriglycan addition","volume":"5","author":"Praissman","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.omtm.2023.05.022_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ana.10559","article-title":"Phenotypic spectrum associated with mutations in the fukutin-related protein gene","volume":"53","author":"Mercuri","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2023.05.022_bib5","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/archneur.62.12.1894","article-title":"Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2i","volume":"62","author":"Boito","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omtm.2023.05.022_bib6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ana.20824","article-title":"High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2i in Denmark","volume":"59","author":"Sveen","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2023.05.022_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.20833","article-title":"Fukutin-related protein localizes to the golgi apparatus and mutations lead to mislocalization in muscle in\u00a0vivo","volume":"36","author":"Keramaris-Vrantsis","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2023.05.022_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/hmg\/ddi026","article-title":"Fukutin-related protein mutations that cause congenital muscular dystrophy result in er-retention of the mutant protein in cultured cells","volume":"14","author":"Esapa","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2023.05.022_bib9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/324412","article-title":"Mutations in the fukutin-related protein gene (fkrp) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan","volume":"69","author":"Brockington","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2023.05.022_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omtn.2018.02.008","article-title":"Overexpression of mutant fkrp restores functional glycosylation and improves dystrophic phenotype in fkrp mutant mice","volume":"11","author":"Tucker","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2023.05.022_bib11","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/mt.2013.156","article-title":"Adeno-associated virus 9 mediated fkrp gene therapy restores functional glycosylation of alpha-dystroglycan and improves muscle functions","volume":"21","author":"Xu","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.omtm.2017.02.002","article-title":"Efficacy of gene therapy is dependent on disease progression in dystrophic mice with mutations in the fkrp gene","volume":"5","author":"Vannoy","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.05.022_bib13","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/hmg\/ddx066","article-title":"Aav-mediated transfer of fkrp shows therapeutic efficacy in a murine model but requires control of gene expression","volume":"26","author":"Gicquel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2023.05.022_bib14","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/hmg\/ddq314","article-title":"Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies","volume":"19","author":"Chan","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2023.05.022_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164187","article-title":"Progressive dystrophic pathology in diaphragm and impairment of cardiac function in fkrp p448l mutant mice","volume":"11","author":"Blaeser","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.05.022_bib16","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/mt.2014.141","article-title":"Muscle and heart function restoration in a limb girdle muscular dystrophy 2i (lgmd2i) mouse model by systemic fkrp gene delivery","volume":"22","author":"Qiao","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib17","first-page":"1137","article-title":"A new mouse model of limb-girdle muscular dystrophy type 2i homozygous for the common l276i mutation mimicking the mild phenotype in humans","volume":"74","author":"Krag","year":"2015","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2023.05.022_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2018.10.004","article-title":"Dose-dependent effects of fkrp gene-replacement therapy on functional rescue and longevity in dystrophic mice","volume":"11","author":"Vannoy","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.05.022_bib19","series-title":"Resource Book for the Design of Animal Exercise Protocols","author":"Kregel","year":"2006"},{"key":"10.1016\/j.omtm.2023.05.022_bib20","series-title":"TREAT-NMD Activity A07: Accelerate Preclinical Phase of New Therapeutic Treatment Development","article-title":"Use of treadmill and wheel exercise for impact on mdx mice phenotype","author":"De Luca","year":"2011"},{"key":"10.1016\/j.omtm.2023.05.022_bib21","series-title":"TREAT-NMD Activity A07: Accelerate Preclinical Phase of New Therapeutic Treatment Development","article-title":"Use of treadmill and wheel exercise to assess dystrophic state","author":"Grange","year":"2011"},{"key":"10.1016\/j.omtm.2023.05.022_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1152\/jappl.1984.56.2.464","article-title":"Ventilatory muscles during exercise in air and oxygen in normal men","volume":"56","author":"Bye","year":"1984","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.omtm.2023.05.022_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1152\/jappl.1982.52.2.388","article-title":"Ventilatory responses at rest and during exercise in marathon runners","volume":"52","author":"Mahler","year":"1982","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.omtm.2023.05.022_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005768-200001000-00012","article-title":"Limiting factors for maximum oxygen uptake and determinants of endurance performance","volume":"32","author":"Bassett","year":"2000","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.omtm.2023.05.022_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0034-5687(94)90051-5","article-title":"Does peak inspiratory flow contribute to setting vo2max? A test of symmorphosis","volume":"95","author":"Lindstedt","year":"1994","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.omtm.2023.05.022_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/02640414.2011.642809","article-title":"What limits vo2max? A symposium held at the bases conference, 6 september 2010","volume":"30","author":"Spurway","year":"2012","journal-title":"J.\u00a0Sports Sci."},{"key":"10.1016\/j.omtm.2023.05.022_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"De Luca","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.omtm.2023.05.022_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mus.20351","article-title":"Chronic exercise accelerates the degeneration-regeneration cycle and downregulates insulin-like growth factor-1 in muscle of mdx mice","volume":"32","author":"Okano","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2023.05.022_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.24184","article-title":"A novel protocol for assessing exercise performance and dystropathophysiology in the mdx mouse","volume":"50","author":"Rocco","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2023.05.022_bib30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1152\/japplphysiol.00287.2017","article-title":"Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i","volume":"123","author":"Maricelli","year":"2017","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.omtm.2023.05.022_bib31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41587-020-0642-9","article-title":"High-dose aav gene therapy deaths","volume":"38","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2023.05.022_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/hum.2020.182","article-title":"Moving forward after two deaths in a gene therapy trial of myotubular myopathy","volume":"31","author":"Wilson","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib33","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic aav by massively parallel in\u00a0vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.05.022_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn4704","article-title":"Semirational bioengineering of aav vectors with increased potency and specificity for systemic gene therapy of muscle disorders","volume":"8","author":"El Andari","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2023.05.022_bib35","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of aav capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2023.05.022_bib36","doi-asserted-by":"crossref","first-page":"E2266","DOI":"10.1002\/humu.21545","article-title":"Disrupted post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (cftr) by a 5'utr mutation is associated with a cftr-related disease","volume":"32","author":"Lukowski","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2023.05.022_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/hmg\/ddu501","article-title":"Cftr mrna expression is regulated by an upstream open reading frame and rna secondary structure in its 5' untranslated region","volume":"24","author":"Lukowski","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2023.05.022_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrm.2017.103","article-title":"Functional 5' utr mrna structures in eukaryotic translation regulation and how to find them","volume":"19","author":"Leppek","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2023.05.022_bib39","first-page":"1584","article-title":"Rna g-quadruplexes: emerging mechanisms in disease","volume":"45","author":"Cammas","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2023.05.022_bib40","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jmb.2017.05.017","article-title":"Rna g-quadruplexes in biology: principles and molecular mechanisms","volume":"429","author":"Fay","year":"2017","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2023.05.022_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level raav-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61737-982-6_1","article-title":"Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles","volume":"709","author":"Himeda","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2023.05.022_bib43","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/mt.2010.308","article-title":"Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes","volume":"19","author":"Gon\u00e7alves","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/hum.2008.197","article-title":"Partial rescue of growth failure in growth hormone (gh)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the gh gene driven by a muscle-specific regulatory cassette","volume":"20","author":"Martari","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib45","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1093\/hmg\/ddv420","article-title":"Progress and prospects of gene therapy clinical trials for the muscular dystrophies","volume":"25","author":"Bengtsson","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2023.05.022_bib46","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/mt.2014.99","article-title":"Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice","volume":"22","author":"Hu","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.25","article-title":"Engraftment potential of dermal fibroblasts following in\u00a0vivo myogenic conversion in immunocompetent dystrophic skeletal muscle","volume":"1","author":"Muir","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2023.05.022_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","article-title":"Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6","volume":"10","author":"Blankinship","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib49","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2023.05.022_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022968","article-title":"Fukutin-related protein resides in the golgi cisternae of skeletal muscle fibres and forms disulfide-linked homodimers via an n-terminal interaction","volume":"6","author":"Alhamidi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2023.05.022_bib51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2023.05.022_bib52","first-page":"H941","article-title":"Use of tibial length to quantify cardiac hypertrophy: application in the aging rat","volume":"243","author":"Yin","year":"1982","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.omtm.2023.05.022_bib53","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14712598.2022.2060737","article-title":"Addressing high dose aav toxicity - 'one and done' or 'slower and lower","volume":"22","author":"Kishimoto","year":"2022","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of aav gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2023.05.022_bib55","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in\u00a0vivo gene therapy with aavs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib56","first-page":"4","article-title":"A collaborative analysis by clinical trial sponsors and academic experts of anti-transgene saes in studies of gene therapy for DMD","volume":"30","author":"Bonnemann","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib57","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1021\/acs.jmedchem.2c00654","article-title":"Selective c9orf72 g-quadruplex-binding small molecules ameliorate pathological signatures of als\/ftd models","volume":"65","author":"Cheng","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omtm.2023.05.022_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba9188","article-title":"Microrna-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by aav vectors in primates","volume":"12","author":"Hordeaux","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2023.05.022_bib59","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/s41467-021-24436-7","article-title":"High-throughput 5' utr engineering for enhanced protein production in non-viral gene therapies","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2023.05.022_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yjmcc.2016.11.011","article-title":"Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of duchenne cardiomyopathy","volume":"102","author":"Wasala","year":"2017","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.omtm.2023.05.022_bib61","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/mus.25378","article-title":"Expression of glycosylated alpha-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (fkrp) mutant mice","volume":"55","author":"Keramaris","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2023.05.022_bib62","series-title":"Resource Book for the Design of Animal Exercise Protocols","author":"Kregel","year":"2006"},{"key":"10.1016\/j.omtm.2023.05.022_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1249\/JES.0000000000000007","article-title":"Skeletal muscle hypertrophy after aerobic exercise training","volume":"42","author":"Konopka","year":"2014","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.omtm.2023.05.022_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2353\/ajpath.2010.090760","article-title":"Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology","volume":"176","author":"Gehrig","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2023.05.022_bib65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0092-8674(88)90463-1","article-title":"Fast muscle fibers are preferentially affected in duchenne muscular dystrophy","volume":"52","author":"Webster","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2023.05.022_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-1-4939-7374-3_18","article-title":"Aav6 vector production and purification for muscle gene therapy","volume":"1687","author":"Halbert","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2023.05.022_bib67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fphys.2013.00034","article-title":"Measuring energy metabolism in the mouse - theoretical, practical, and analytical considerations","volume":"4","author":"Speakman","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2023.05.022_bib68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/hum.2017.158","article-title":"Systemic smad7 gene therapy increases striated muscle mass and enhances exercise capacity in a dose-dependent manner","volume":"29","author":"Maricelli","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2023.05.022_bib69","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0070-2153(08)00609-1","article-title":"The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies","volume":"84","author":"Banks","year":"2008","journal-title":"Curr. Top. Dev. Biol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050123000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T01:36:54Z","timestamp":1714786614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050123000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":69,"alternative-id":["S2329050123000840"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2023.05.022","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and muscle safety assessment of fukutin-related protein gene therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2023.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}